Results from a 52-week randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular wnt pathway inhibitor (SM04690) for the treatment of knee osteoarthritis

Authors :: Christopher J. Swearingen
Morgan H. Jones
M. Hochberg
Allan Gibofsky
John A. Bergfeld
A. DiFrancesco
Nancy E Lane
Timothy E. McAlindon
Daniel J. Clauw
Yusuf Yazici
J. Tambiah
Source :: Osteoarthritis and Cartilage. 26:S293-S294
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
medicine.medical_specialty
business.industry
Biomedical Engineering
Urology
Wnt signaling pathway
Phases of clinical research
Osteoarthritis
medicine.disease
Placebo
Double blind
03 medical and health sciences
030104 developmental biology
Intra articular
Rheumatology
medicine
Orthopedics and Sports Medicine
business

Full Text Access

Tools